SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 1/05/11 Ziopharm Oncology Inc 8-K:8,9 12/29/10 2:60K Vintage/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 21K 2: EX-99.1 Miscellaneous Exhibit HTML 17K
Delaware
|
84-1475642
|
|||
(State
or Other Jurisdiction
of
Incorporation)
|
(Commission
File Number)
|
(IRS
Employer
Identification
No.)
|
1180
Avenue of the Americas
19th
Floor
New
York, NY
|
10036
|
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b)).
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c)).
|
(d)
|
Exhibits
|
||
Exhibit No.
|
Description
|
||
99.1
|
Press
Release dated December 29, 2010
|
ZIOPHARM
Oncology, Inc.
|
||
By:
|
/s/ Richard Bagley
|
|
Date:
January 5, 2011
|
Name:
Richard Bagley
|
|
Title:
President, Chief Operating Officer and Chief
Financial
Officer
|
Exhibit No.
|
Description
|
|
99.1
|
Press
Release dated December 29,
2010
|
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 1/5/11 | None on these Dates | ||
For Period End: | 12/29/10 | |||
List all Filings |